Humana Inc. (NYSE:HUM) has coverage initiated with a Neutral rating

Analyst Ratings For Humana Inc. (NYSE:HUM)

Story continues below

Today, UBS Group initiated coverage on Humana Inc. (NYSE:HUM) with a Neutral.

There are 13 Buy Ratings, 4 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on Humana Inc. (NYSE:HUM) is Buy with a consensus target price of $355.5013 per share, a potential 46.54% upside.

Some recent analyst ratings include

  • 4/23/2019-Humana Inc. (NYSE:HUM) has coverage initiated with a Neutral rating
  • 1/14/2019-Humana Inc. (NYSE:HUM) has coverage initiated with a Overweight rating and $336.00 price target
  • 1/11/2019-Humana Inc. (NYSE:HUM) gets upgraded to Outperform by Cowen with a price target of $275.02
  • 1/2/2019-Humana Inc. (NYSE:HUM) had its Hold rating reiterated by Cantor Fitzgerald with a $325.00 price target
  • On 2/25/2019 Christopher H Hunter, Insider, sold 15,586 with an average share price of $305.24 per share and the total transaction amounting to $4,757,470.64.
  • On 2/19/2019 Roy A Beveridge, Insider, sold 8,278 with an average share price of $307.16 per share and the total transaction amounting to $2,542,670.48.
  • On 12/18/2018 Heidi S Margulis, Insider, sold 2,656 with an average share price of $296.22 per share and the total transaction amounting to $786,760.32.
  • On 11/16/2018 David A. Jr/Ky Jones, Director, sold 600 with an average share price of $88.05 per share and the total transaction amounting to $52,830.00.
  • On 11/8/2018 Roy A Beveridge, Insider, sold 4,622 with an average share price of $341.06 per share and the total transaction amounting to $1,576,379.32.
  • On 9/10/2018 Bruce D Broussard, CEO, sold 18,000 with an average share price of $328.66 per share and the total transaction amounting to $5,915,880.00.
  • On 8/16/2018 Elizabeth D Bierbower, Insider, sold 3,092 with an average share price of $330.00 per share and the total transaction amounting to $1,020,360.00.

About Humana Inc. (NYSE:HUM)
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2018, the company had approximately 17 million members in medical benefit plans, as well as approximately 6 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Recent Trading Activity for Humana Inc. (NYSE:HUM)
Shares of Humana Inc. closed the previous trading session at 242,60 up +1,55 0,64 % with 241.32 shares trading hands.

An ad to help with our costs